SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:08 pm Purchase |
2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,572,836 5.700% |
723,898 (+18.81%) |
Filing |
| 2023-02-13 1:31 pm Purchase |
2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,848,938 5.700% |
8,600 (+0.22%) |
Filing |
| 2022-11-02 09:35 am Purchase |
2022-10-21 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,840,338 5.600% |
3,840,338 (New Position) |
Filing |